Cambridge Cognition Holdings Plc (COG.L)
LSE · GBp · Healthcare · Health Information Services
£28.00 (+3.70%) as of
Key statistics
- Market cap
- 15.11M
- Forward P/E
- -10.46
- EPS (TTM)
- -0.03
- Dividend yield
- 0.00%
- 52-week range
- 26.60 – 45.00
- Beta
- 0.81
- Revenue (TTM)
- 10.13M
- Profit margin
- -13.86%
- Analyst target
- £61.67
- Volume
- 647.00
About Cambridge Cognition Holdings Plc
Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers sensitive, precise and objective measures of cognitive function, correlated to neural networks; voice analysis, an automated speech recognition tool for monitoring neurological and psychiatric disorders; and high frequency testing that detects fluctuations in brain health with short tasks over regular timepoints. It also provides electronic questionnaires and scales (eCOA), a digital bespoke questionnaires that collects data within tight deadlines; and data quality management. Cambridge Cognition Holdings Plc was incorporated in 2012 and is headquartered in Cambridge, the United Kingdom.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Cambridge, United Kingdom
- Employees
- 74
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.